"Computational drug repurposing reveals Alectinib as a potential lead ..."

Mohammed Alrouji et al. (2025)

> Home

Details and statistics

DOI: 10.3389/FBINF.2025.1666573

access: closed

type: Journal Article

metadata version: 2026-04-10

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - journals/fbinf/AlroujiAATDSA25
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/fbinf/AlroujiAATDSA25
Mohammed Alrouji, Mohammed S. Alshammari, Sharif Alhajlah, Syed Tasqeeruddin, Khuzin Dinislam, Anas Shamsi, Saleha Anwar:
Computational drug repurposing reveals Alectinib as a potential lead targeting Cathepsin S for therapeutic developments against cancer and chronic pain. Frontiers Bioinform. 5 (2025)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.